1. |
IOM (Institute of Medicine). 2011. Clinical Practice Guidelines We Can Trust. Washington, DC:The National Academies Press.
|
2. |
Woolf SH, Grol R, Hutchinson A, et al. Potential benefits, limitations, and harms of clinical guidelines. BMJ, 1999, 318(7182):527-530.
|
3. |
Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice:a systematic review of rigorous evaluations. Lancet, 1993, 342(8883):1317-1322.
|
4. |
WHO. Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. General:WHO, 2000.
|
5. |
WHO. WHO traditional medicine strategy 2002-2005. General:WHO, 2002.
|
6. |
中华人民共和国国民经济和社会发展第十一个五年规划纲要.[2016-1-26]. Available at:http://news.xinhuanet.com/misc/2006-03/16/content_4309517.htm.
|
7. |
李楠, 姚亮, 吴琼芳, 等. 2012-2013年中国大陆期刊发表临床实践指南质量评价.中国循证医学杂志, 2015, 15(3):259-263.
|
8. |
Consortium ANS. The AGREE Ⅱ Instrument. The AGREE Research Trust. 2009:1.
|
9. |
Brouwers MC, Kho ME, Browman GP, et al. AGREE II:advancing guideline development, reporting and evaluation in health care. CMAJ, 2010, 182(18):E839-E842.
|
10. |
Zadvinskis IM, Grudell BA. Clinical practice guideline appraisal using the AGREE instrument:renal screening. Clin Nurse Spec, 2010, 24(4):209-214.
|
11. |
Field MJ, Lohr KN. Guidelines for Clinical Practice:From Development to Use:National Academies Press, 1992.
|
12. |
Field MJ. Setting priorities for clinical practice guidelines:National Academies Press, 1995.
|
13. |
Chen YL, Yao L, Xiao XX, et al. Quality assessment of clinical guidelines in China:1993-2010. Chin Med J (Engl), 2012, 125(20):3660-3664.
|
14. |
潘晓平, 倪宗瓒.组内相关系数在信度评价中的应用.华西医科大学学报, 1999, 30(1):62-63.
|
15. |
余红梅, 罗艳虹, 萨建, 等.组内相关系数及其软件实现.中国卫生统计, 2011, 28(5):497-500.
|
16. |
AGREE History.[2016-01-23]. Available at:http://www.agreetrust.org/about-agree/agree-history/.
|
17. |
Alonso-Coello P, Irfan A, Solà I, et al. The quality of clinical practice guidelines over the last two decades:a systematic review of guideline appraisal studies. Qual Saf Health Care, 2010, 19(6):e58.
|
18. |
陈敏, 何佳, 肖飏, 等.国内期刊发表的中医药系统评价/Meta分析的现状分析.中国循证医学杂志, 2012, 119(12):1526-1530.
|
19. |
李廷谦, 刘雪梅, 张鸣明, 等.中文期刊发表的中医药系统评价/Meta分析现状调查.中国循证医学杂志, 2007, 50(3):180-188.
|
20. |
刘建平, 夏芸.中文期刊发表的中医药系统综述或Meta分析文章的质量评价.中国中西医结合杂志, 2007, 27(4):306-311.
|
21. |
卫茂玲, 刘鸣.中国临床指南循证制定的方法学现状分析.中国循证医学杂志, 2013, 3(8):927-932.
|
22. |
吕爱平, 谢雁鸣, 韩学杰.基于循证医学的中医临床实践指南编制方法与范例.中国中医药出版社, 2013.
|
23. |
刘筱敏.中国科学引文数据库来源期刊出版规模浅析.中国科技期刊研究, 2008, 19(6):935-937.
|
24. |
刘筱敏.中国科学引文数据库与期刊网络化.中国科技期刊研究, 2003, 14(z1):810-813.
|
25. |
Norris SL, Holmer HK, Ogden LA, et al. Conflict of Interest Disclosures for Clinical Practice Guidelines in the National Guideline Clearinghouse. PLoS ONE, 2012, 7(11):e47343.
|
26. |
Norris SL, Holmer HK, Ogden LA, et al. Conflict of Interest in Clinical Practice Guideline Development:A Systematic Review. PLoS ONE, 2011, 6(10):e25153.
|
27. |
陈耀龙, 杨克虎, 田金徽, 等.循证实践指南的制定:国际经验与中国实践.兰州大学学报(医学版), 2016, 42(1):29-35.
|
28. |
李幼平, 李静, 孙鑫, 等.循证医学在中国的发展:回顾与展望.兰州大学学报(医学版), 2016, 42(1):25-28.
|